{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:39:29Z","timestamp":1794335969095,"version":"4.9.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Scientists, clinicians, and other experts aim to maximize the benefits of cancer screening while minimizing its harms. Chief among these harms are overdiagnosis and overtreatment. Although available data suggest that patient awareness of these harms is low, we know little about how patients respond to information about these phenomena.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Using the case of breast cancer screening, this study assesses women\u2019s awareness of and reactions to statements about overdiagnosis and overtreatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We draw on data from a 2016 population-based survey of US women aged 35\u201355 years that oversampled women of lower socioeconomic position (those living at or below 100% of federal poverty level) (N=429).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Results showed that women\u2019s awareness of overdiagnosis (16.5%) and overtreatment (18.0%) was low, and women under age 40 were least likely to have heard about overdiagnosis. Most women did not evaluate statements about these harms positively: &lt;1 in 4 agreed with and found statements about overdiagnosis and overtreatment to be believable, and even fewer evaluated them as strong arguments to consider in their own mammography decision making. Women with a recent mammogram history were particularly unconvinced by overdiagnosis and overtreatment arguments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>A majority of women were unaware of 2 important harms of breast cancer screening: overdiagnosis and overtreatment. Most did not find statements about these harms to be believable and persuasive. Communication interventions, supported by evidence from health communication research, are necessary to improve patient understanding of screening\u2019s harms, promote informed decision making, and, in turn, ensure high-value care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mlr.0000000000000798","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T23:32:49Z","timestamp":1504049569000},"page":"879-885","source":"Crossref","is-referenced-by-count":34,"title":["Women\u2019s Awareness of and Responses to Messages About Breast Cancer Overdiagnosis and Overtreatment"],"prefix":"10.1097","volume":"55","author":[{"given":"Rebekah H.","family":"Nagler","sequence":"first","affiliation":[{"name":"Hubbard School of Journalism and Mass Communication, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Franklin Fowler","sequence":"additional","affiliation":[{"name":"Department of Government, Wesleyan University, Middletown, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Gollust","sequence":"additional","affiliation":[{"name":"Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230821","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/M14-2327","article-title":"A value framework for cancer screening: advice for high-value care from the American College of Physicians","volume":"162","author":"Harris","year":"2015","journal-title":"Ann Intern Med"},{"key":"R2-20230821","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jnci\/djq099","article-title":"Overdiagnosis in cancer","volume":"102","author":"Welch","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"suppl 1","key":"R3-20230821","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1089\/pop.2015.29023.mor","article-title":"Implications of overdiagnosis: impact on screening mammography practices","volume":"18","author":"Morris","year":"2015","journal-title":"Popul Health Manag"},{"key":"R4-20230821","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7326\/M16-0270","article-title":"Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis","volume":"166","author":"J\u00f8rgensen","year":"2017","journal-title":"Ann Intern Med"},{"key":"R6-20230821","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.whi.2015.04.011","article-title":"Covering controversy: what are the implications for women\u2019s health?","volume":"25","author":"Nagler","year":"2015","journal-title":"Womens Health Issues"},{"key":"R7-20230821","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s10865-014-9572-7","article-title":"Have screening harms become newsworthy? News coverage of prostate and colorectal cancer screening since the 2008 USPSTF recommendation changes","volume":"37","author":"Elstad","year":"2014","journal-title":"J Behav Med"},{"key":"R8-20230821","doi-asserted-by":"crossref","first-page":"e0152279","DOI":"10.1371\/journal.pone.0152279","article-title":"Information on \u201coverdiagnosis\u201d in breast cancer screening on prominent United Kingdom and Australia-oriented health websites","volume":"11","author":"Ghanouni","year":"2016","journal-title":"PLoS One"},{"key":"R9-20230821","doi-asserted-by":"crossref","first-page":"e0125165","DOI":"10.1371\/journal.pone.0125165","article-title":"Public opinions about overdiagnosis: a national community survey","volume":"10","author":"Moynihan","year":"2015","journal-title":"PLoS One"},{"key":"R10-20230821","doi-asserted-by":"crossref","first-page":"e010723","DOI":"10.1136\/bmjopen-2015-010723","article-title":"Survey of public definitions of the term \u201coverdiagnosis\u201d in the UK","volume":"6","author":"Ghanouni","year":"2016","journal-title":"BMJ Open"},{"key":"R11-20230821","doi-asserted-by":"crossref","first-page":"h980","DOI":"10.1136\/bmj.h980","article-title":"People\u2019s willingness to accept overdetection in cancer screening: population survey","volume":"350","author":"Van den Bruel","year":"2015","journal-title":"BMJ"},{"key":"R12-20230821","doi-asserted-by":"crossref","first-page":"e007436","DOI":"10.1136\/bmjopen-2014-007436","article-title":"What do you think overdiagnosis means? A qualitative analysis of responses from a national community survey of Australians","volume":"5","author":"Moynihan","year":"2015","journal-title":"BMJ Open"},{"key":"R13-20230821","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/bmjopen-2013-002703","article-title":"Women\u2019s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study","volume":"3","author":"Waller","year":"2013","journal-title":"BMJ Open"},{"key":"R14-20230821","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.f158","article-title":"Women\u2019s views on overdiagnosis in breast cancer screening: a qualitative study","volume":"346","author":"Hersch","year":"2013","journal-title":"BMJ"},{"key":"R15-20230821","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2017.2247","article-title":"Women\u2019s awareness and perceived importance of the harms and benefits of mammography screening: results from a 2016 National Survey","author":"Yu","year":"2017","journal-title":"JAMA Intern Med"},{"key":"R16-20230821","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.291.1.71","article-title":"Enthusiasm for cancer screening in the United States","volume":"291","author":"Schwartz","year":"2004","journal-title":"JAMA"},{"key":"R17-20230821","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(15)60123-4","article-title":"Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial","volume":"385","author":"Hersch","year":"2015","journal-title":"Lancet"},{"key":"R18-20230821","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/ACM.0000000000000270","article-title":"Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign","volume":"89","author":"Wolfson","year":"2014","journal-title":"Acad Med"},{"key":"R19-20230821","doi-asserted-by":"crossref","first-page":"i348","DOI":"10.1136\/bmj.i348","article-title":"Walking the tightrope: communicating overdiagnosis in modern healthcare","volume":"352","author":"McCaffery","year":"2016","journal-title":"BMJ"},{"key":"R20-20230821","doi-asserted-by":"crossref","first-page":"h6967","DOI":"10.1136\/bmj.h6967","article-title":"Full disclosure about cancer screening","volume":"352","author":"Gigerenzer","year":"2016","journal-title":"BMJ"},{"key":"R21-20230821","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/19312458.2010.547822","article-title":"A measure of perceived argument strength: reliability and validity","volume":"5","author":"Zhao","year":"2011","journal-title":"Commun Methods Meas"},{"key":"R22-20230821","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10810730.2013.821561","article-title":"Understanding public resistance to messages about health disparities","volume":"19","author":"Gollust","year":"2014","journal-title":"J Health Commun"},{"key":"R23-20230821","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.2105\/AJPH.2013.301271","article-title":"Framing the consequences of childhood obesity to increase public support for obesity prevention policy","volume":"103","author":"Gollust","year":"2013","journal-title":"Am J Public Health"},{"key":"R24-20230821","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/10810730.2015.1018593","article-title":"Do emotional appeals in public service advertisements influence adolescents\u2019 intention to reduce consumption of sugar-sweetened beverages?","volume":"20","author":"Bleakley","year":"2015","journal-title":"J Health Commun"},{"key":"R25-20230821","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ntr\/ntq255","article-title":"Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs","volume":"13","author":"Lee","year":"2011","journal-title":"Nicotine Tob Res"},{"key":"R26-20230821","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jamainternmed.2013.10363","article-title":"Less is more: overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms","volume":"173","author":"Wegwarth","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R27-20230821","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamainternmed.2016.8254","article-title":"Clinicians\u2019 expectations of the benefits and harms of treatments, screening, and tests: a systematic review","volume":"177","author":"Hoffmann","year":"2017","journal-title":"JAMA Intern Med"},{"key":"R28-20230821","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0272989X15587676","article-title":"Understanding the harms and benefits of cancer screening: a model of factors that shape informed decision making","volume":"35","author":"Petrova","year":"2015","journal-title":"Med Decis Making"},{"key":"R29-20230821","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMms1409003","article-title":"Invisible risks, emotional choices\u2014mammography and medical decision making","volume":"371","author":"Rosenbaum","year":"2014","journal-title":"N Engl J Med"},{"key":"R30-20230821","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamainternmed.2014.6016","article-title":"Patients\u2019 expectations of the benefits and harms of treatments, screening, and tests: a systematic review","volume":"175","author":"Hoffmann","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R31-20230821","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bjc.2014.643","article-title":"Enthusiasm for cancer screening in Great Britain: a general population survey","volume":"112","author":"Waller","year":"2015","journal-title":"Br J Cancer"},{"key":"R32-20230821","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/bmj.320.7250.1635","article-title":"US women\u2019s attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey","volume":"320","author":"Schwartz","year":"2000","journal-title":"BMJ"},{"key":"R33-20230821","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pec.2011.08.002","article-title":"Disparities in patient reports of communications to inform decision making in the DECISIONS survey","volume":"87","author":"Zikmund-Fisher","year":"2012","journal-title":"Patient Educ Couns"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005650-201710000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T04:21:09Z","timestamp":1692678069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005650-201710000-00003"}},"subtitle":["Results From a 2016 National Survey"],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mlr.0000000000000798","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}